Measles (Rubeola) Antibody, IgM, CSF
Ordering Recommendation
Aid in the diagnosis of measles encephalitis. False-positive results will occur due to low incidence of measles in the U.S.
New York DOH Approval Status
Specimen Required
CSF.
Transfer 0.5 mL CSF to an ARUP Standard Transport Tube. (Min: 0.2 mL)
New York State Clients: 1 mL (Min: 0.075 mL)
Refrigerated. Also acceptable: Frozen.
New York State Clients: Refrigerated
Bacterially contaminated, heat-inactivated, hemolyzed, or xanthochromic specimens.
Ambient: 8 hours; Refrigerated: 2 weeks; Frozen: 1 year
New York State Clients: Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 month
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Performed
Mon-Fri
Reported
1-5 days
Reference Interval
0.79 AU or less | Negative - No significant level of IgM antibodies to measles (rubeola) virus detected. |
0.80-1.20 AU | Equivocal - Repeat testing in 10-14 days may be helpful. |
1.21 AU or greater | Positive - IgM antibodies to measles (rubeola) virus detected. Suggestive of current or recent infection or immunization. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-infection or immunization. |
Interpretive Data
The detection of antibodies to rubeola in CSF may indicate central nervous system infection. However, consideration must be given to possible contamination by blood or transfer of serum antibodies across the blood-brain barrier.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
CPT Codes
86765
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0054441 | Measles, Rubeola, Antibody IgM CSF | 13283-7 |
Aliases
- English Measles
- measles IgM CSF
- MMR
- Rubeola IgM CSF